
Nuvectis Pharma (NVCT) Earnings Dates & Reports
Nuvectis Pharma (NVCT) Most Recent Earnings
Report DateMay 6, 2025
Period EndingQ1 2025
Est. EPS-$0.25
Actual EPS-$0.27
EarningsMiss
Nuvectis Pharma (NVCT) Earnings
View the latest Nuvectis Pharma (NVCT) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Nuvectis Pharma (NVCT)
Order type
Buy in
Order amount
Est. shares
0 shares
Nuvectis Pharma (NVCT) Earnings per Share (EPS) History
Signup for full accessBrowse free
Nuvectis Pharma (NVCT) Latest Earnings
The value each NVCT share was expected to gain vs. the value each share gained.
Nuvectis Pharma (NVCT) reported its most recent earnings on May 6, 2025 for Q1 2025, posting earnings per share (EPS) of -$0.27. This exceeded analysts' expectations of -$0.25 by 8.00%, marking a Miss.
For comparison, Nuvectis Pharma reported EPS of -$0.25 in the same quarter last year.
The company is expected to announce its next earnings report on 08/05/2025, with analysts projecting an EPS of $0.
Nuvectis Pharma (NVCT) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q2 2025Aug 5, 2025 | – | Next earnings call Aug. 5, 2025 | ||
Q1 2025May 6, 2025 | -$0.25 | -$0.27 | +8.00% | |
Q4 2024Feb 25, 2025 | -$0.28 | -$0.36 | +28.57% | |
Q3 2024Nov 5, 2024 | -$0.25 | -$0.24 | -4.00% | |
Q2 2024Aug 6, 2024 | -$0.26 | -$0.26 | 0.00% | |
Nuvectis Pharma (NVCT) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Nuvectis Pharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 6, 2025 | — | — | — |
Feb 25, 2025 | — | — | — |
Nov 5, 2024 | — | — | — |
Aug 6, 2024 | — | — | — |
Nuvectis Pharma (NVCT) Earnings FAQs
Nuvectis Pharma (NVCT) last reported earnings on May 6, 2025 for Q1 2025, posting an EPS of -$0.27, which Miss the estimate of -$0.25 by 8.00%.
For Q1 2025, Nuvectis Pharma (NVCT) reported an EPS of -$0.27, missing analysts' estimate of -$0.25 by 8.00%.
For Q1 2025, Nuvectis Pharma (NVCT) Miss expectations with an actual EPS of -$0.27 vs. an estimated EPS of -$0.25.
Following the last earnings report on May 6, 2025, Nuvectis Pharma (NVCT)'s stock price moved — from — to —.
The next Nuvectis Pharma (NVCT) earnings call is scheduled for Aug. 5, 2025, where executives will discuss financial results and outlook.